Literature DB >> 29161228

Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness.

Emily Leickly1,2,3,4, Jordan Skalisky1,2,3, Oladunni Oluwoye1,2,3, Sterling M McPherson2,3,5, Debra Srebnik6, John M Roll2,3, Richard K Ries2,6, Michael G McDonell1,2,3.   

Abstract

BACKGROUND: Adults experiencing homelessness and serious mental illnesses (SMI) are at an increased risk of poor mental health and treatment outcomes compared with stably housed adults with SMI. The additional issue of alcohol misuse further complicates the difficulties of those living with homelessness and SMI. In this secondary data analysis, the authors investigated the impact of homelessness on attrition and alcohol use in a contingency management (CM) intervention that rewarded alcohol abstinence in outpatients with SMI.
METHODS: The associations between housing status and attrition and alcohol abstinence during treatment, as assessed by ethyl glucuronide (EtG) urine tests, were evaluated in 79 adults diagnosed with alcohol dependence and SMI.
RESULTS: Thirty-nine percent (n = 31) of participants reported being homeless at baseline. Individuals who were homeless were more likely to drop out of CM (n = 10, 62.5%) than those who were housed (n = 4, 16.7%), χ2(1) = 8.86, P < .05. Homelessness was not associated with attrition in the noncontingent control group. Accounting for treatment group and prerandomization EtG levels, neither the effect of housing status nor the interaction of housing status and group were associated with EtG-assessed alcohol abstinence during treatment.
CONCLUSIONS: Individuals experiencing homelessness and co-occurring alcohol dependence and SMI receiving CM had higher rates of attrition, relative to those who were housed. Homelessness was not associated with differences in biologically assessed alcohol abstinence.

Entities:  

Keywords:  Addiction treatment; alcohol use disorder; contingency management; homelessness; serious mental illness; substance use

Mesh:

Substances:

Year:  2017        PMID: 29161228      PMCID: PMC6146065          DOI: 10.1080/08897077.2017.1391926

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  15 in total

1.  Contingency Management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders.

Authors:  Kathlene Tracy; Theresa Babuscio; Charla Nich; Brian Kiluk; Kathleen M Carroll; Nancy M Petry; Bruce J Rounsaville
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

2.  A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adults.

Authors:  Mikhail N Koffarnus; Conrad J Wong; Karly Diemer; Mick Needham; Jacqueline Hampton; Michael Fingerhood; Dace S Svikis; George E Bigelow; Kenneth Silverman
Journal:  Alcohol Alcohol       Date:  2011-05-27       Impact factor: 2.826

3.  External influences on drug treatment interventions: East Palo Alto's Free-at-Last.

Authors:  Benjamin Paul Bowser; David Lewis; Derrick Dogan
Journal:  J Addict Med       Date:  2011-06       Impact factor: 3.702

4.  Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.

Authors:  Michael Gerard McDonell; Emily Leickly; Sterling McPherson; Jordan Skalisky; Katherine Hirchak; Oladunni Oluwoye; Debra Srebnik; John Michael Roll; Richard Kirkland Ries
Journal:  Am J Addict       Date:  2017-08-18

5.  A Multiple-City RCT of Housing First With Assertive Community Treatment for Homeless Canadians With Serious Mental Illness.

Authors:  Tim Aubry; Paula Goering; Scott Veldhuizen; Carol E Adair; Jimmy Bourque; Jino Distasio; Eric Latimer; Vicky Stergiopoulos; Julian Somers; David L Streiner; Sam Tsemberis
Journal:  Psychiatr Serv       Date:  2015-12-01       Impact factor: 3.084

6.  A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.

Authors:  Michael G McDonell; Emily Leickly; Sterling McPherson; Jordan Skalisky; Debra Srebnik; Frank Angelo; Roger Vilardaga; Jenny R Nepom; John M Roll; Richard K Ries
Journal:  Am J Psychiatry       Date:  2017-01-31       Impact factor: 18.112

7.  Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system.

Authors:  David P Folsom; William Hawthorne; Laurie Lindamer; Todd Gilmer; Anne Bailey; Shahrokh Golshan; Piedad Garcia; Jürgen Unützer; Richard Hough; Dilip V Jeste
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

8.  Improving outcomes for homeless people with alcohol disorders: a multi-program community-based approach.

Authors:  Gary A Morse; Mary M York; Nathaniel Dell; Julie Blanco; Chelsea Birchmier
Journal:  J Ment Health       Date:  2017-07-07

9.  To house or not to house: the effects of providing housing to homeless substance abusers in treatment.

Authors:  Jesse B Milby; Joseph E Schumacher; Dennis Wallace; Michelle J Freedman; Rudy E Vuchinich
Journal:  Am J Public Health       Date:  2005-07       Impact factor: 9.308

Review 10.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

View more
  1 in total

1.  Mixed-methods trial of a phosphatidylethanol-based contingency management intervention to initiate and maintain alcohol abstinence in formerly homeless adults with alcohol use disorders.

Authors:  Elizabeth R Fraser; Nathalie Hill-Kapturczak; Julianne Jett; Rachael Beck; Oladunni Oluwoye; Liat S Kriegel; Karl C Alcover; Sterling McPherson; Leopoldo J Cabassa; Martin Javors; Michael G McDonell
Journal:  Contemp Clin Trials Commun       Date:  2021-03-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.